SCHEMBL18166567

SCHEMBL18166567

Cn1c(=O)c2c(ncn2CC(=O)NCCc2ccccc2Br)n(C)c1=O

nearest known ligand 0.63

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 6/20 0.61
▸ TP53 P04637 4/20 0.61
▸ MAPK1 P28482 2/20 0.61
▸ CYP1A2 P05177 2/20 0.61
▸ CYP3A4 P08684 1/20 0.61
▸ LMNA P02545 2/20 0.58
▸ GAA P10253 1/20 0.57
▸ ALOX15 P16050 1/20 0.56
▸ KMT2A Q03164 2/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ ALDH1A1 P00352 2/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ NPSR1 Q6W5P4 1/20 0.54
▸ ADORA2B P29275 1/20 0.54
▸ PORCN Q9H237 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1067104 0.89 CYP1A2 (0.69) RXFP1TP53MAPK1CYP1A2CYP3A4
SCHEMBL1063738 0.88 RXFP1 (0.61) RXFP1TP53MAPK1CYP1A2CYP3A4
SCHEMBL1065506 0.88 TP53 (0.64) RXFP1TP53MAPK1CYP1A2CYP3A4
SCHEMBL1064143 0.86 CYP1A2 (0.72) RXFP1TP53MAPK1CYP1A2CYP3A4
SCHEMBL20161764 0.85 CYP1A2 (0.71) RXFP1TP53MAPK1CYP1A2CYP3A4
SCHEMBL18166598 0.84 RXFP1 (0.71) RXFP1TP53MAPK1CYP1A2CYP3A4
SCHEMBL5462777 0.84 RXFP1 (0.78) RXFP1TP53MAPK1CYP1A2CYP3A4
SCHEMBL18166737 0.84 CYP1A2 (0.71) RXFP1TP53MAPK1CYP1A2CYP3A4
SCHEMBL10113988 0.83 RXFP1 (0.62) RXFP1TP53MAPK1CYP1A2CYP3A4
SCHEMBL18166590 0.82 CYP1A2 (0.69) RXFP1TP53MAPK1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3663295-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL ELI LILLY AND CO. (US) 2020-06-10 — — EP disclosed
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 — — EP disclosed
EP-2170309-B1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL HYDRA BIOSCIENCES INC (US) 2016-10-26 — — EP disclosed
Send feedback